{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:09:09Z","timestamp":1794953349284,"version":"4.9.1"},"reference-count":229,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1038\/s41568-022-00494-x","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T12:09:59Z","timestamp":1658232599000},"page":"576-591","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Aristolochic acid-associated cancers: a public health risk in need of global action"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7672-3374","authenticated-orcid":false,"given":"Samrat","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8252-8671","authenticated-orcid":false,"given":"Shefali","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3242-7968","authenticated-orcid":false,"given":"Michael","family":"Korenjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3881-5702","authenticated-orcid":false,"given":"Viktoriya S.","family":"Sidorenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1043-4948","authenticated-orcid":false,"given":"Felicia Fei-Lei","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0640-5562","authenticated-orcid":false,"given":"Jiri","family":"Zavadil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"key":"494_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1039\/b303648k","volume":"20","author":"V Kumar","year":"2003","unstructured":"Kumar, V., Poonam, Prasad, A. K. & Parmar, V. S. Naturally occurring aristolactams, aristolochic acids and dioxoaporphines and their biological activities. Nat. Product. Rep. 20, 565\u2013583 (2003).","journal-title":"Nat. Product. Rep."},{"key":"494_CR2","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3389\/fphar.2019.00648","volume":"10","author":"J Han","year":"2019","unstructured":"Han, J., Xian, Z., Zhang, Y., Liu, J. & Liang, A. Systematic overview of aristolochic acids: nephrotoxicity, carcinogenicity, and underlying mechanisms. Front. Pharmacol. 10, 648 (2019).","journal-title":"Front. Pharmacol."},{"key":"494_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1021\/acs.jnatprod.5b00556","volume":"79","author":"J Michl","year":"2016","unstructured":"Michl, J. et al. LC-MS- and 1H NMR-based metabolomic analysis and in vitro toxicological assessment of 43 Aristolochia species. J. Nat. Products 79, 30\u201337 (2016).","journal-title":"J. Nat. Products"},{"key":"494_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00215","author":"J Michl","year":"2017","unstructured":"Michl, J., Bello, O., Kite, G. C., Simmonds, M. S. J. & Heinrich, M. Medicinally used Asarum species: high-resolution LC-MS analysis of aristolochic acid analogs and in vitro toxicity screening in HK-2 cells. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2017.00215 (2017).","journal-title":"Front. Pharmacol."},{"key":"494_CR5","first-page":"3","volume":"53","author":"J Scarborough","year":"2011","unstructured":"Scarborough, J. & Fernandes, A. Ancient medicinal use of Aristolochia: Birthwort\u2019s tradition and toxicity. Pharm. Hist. 53, 3\u201321 (2011).","journal-title":"Pharm. Hist."},{"key":"494_CR6","first-page":"355","volume":"93","author":"T Tomlinson","year":"2020","unstructured":"Tomlinson, T., Fernandes, A. & Grollman, A. P. Aristolochia herbs and iatrogenic disease: the case of Portland\u2019s powders. Yale J. Biol. Med. 93, 355\u2013363 (2020).","journal-title":"Yale J. Biol. Med."},{"key":"494_CR7","doi-asserted-by":"crossref","unstructured":"Grollman, A. P., Scarborough, J. & Jelakovi\u0107, B. In: Advances in Molecular Toxicology Vol. 3 211\u2013227 (Elsevier, 2009).","DOI":"10.1016\/S1872-0854(09)00007-1"},{"key":"494_CR8","first-page":"1","volume":"100","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.","year":"2012","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Pharmaceuticals. Volume 100A. A review of human carcinogens. IARC Monogr. Eval. Carcinog. Risks Hum. 100, 1\u2013401 (2012). In this volume of the IARC Monographs, the Working Group on the Evaluation of Carcinogenic Risks to Humans conducts a re-evaluation of AA and determines that the evidence available warrants its classification as a group 1 carcinogen.","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"key":"494_CR9","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1056\/NEJM200310163491619","volume":"349","author":"LS Gold","year":"2003","unstructured":"Gold, L. S. & Slone, T. H. Aristolochic acid, an herbal carcinogen, sold on the web after FDA alert. N. Engl. J. Med. 349, 1576\u20131577 (2003).","journal-title":"N. Engl. J. Med."},{"key":"494_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/mutage\/17.4.265","volume":"17","author":"VM Arlt","year":"2002","unstructured":"Arlt, V. M., Stiborova, M. & Schmeiser, H. H. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 17, 265\u2013277 (2002).","journal-title":"Mutagenesis"},{"key":"494_CR11","doi-asserted-by":"publisher","first-page":"eaan6446","DOI":"10.1126\/scitranslmed.aan6446","volume":"9","author":"AW Ng","year":"2017","unstructured":"Ng, A. W. et al. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Sci. Transl. Med. 9, eaan6446 (2017). This study reports that an alarmingly high proportion (78%) of HCCs from patients treated in Taiwan harboured the AA mutational signature, and was among the first to examine the disparities in the occurrence of the AA mutational signature between patients with HCC in different countries.","journal-title":"Sci. Transl. Med."},{"key":"494_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00216-007-1310-3","volume":"389","author":"MJ Martena","year":"2007","unstructured":"Martena, M. J. et al. Enforcement of the ban on aristolochic acids in Chinese traditional herbal preparations on the Dutch market. Anal. Bioanal. Chem. 389, 263\u2013275 (2007).","journal-title":"Anal. Bioanal. Chem."},{"key":"494_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ki.2008.129","volume":"74","author":"FD Debelle","year":"2008","unstructured":"Debelle, F. D., Vanherweghem, J.-L. & Nortier, J. L. Aristolochic acid nephropathy: a worldwide problem. Kidney Int. 74, 158\u2013169 (2008).","journal-title":"Kidney Int."},{"key":"494_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep11318","volume":"5","author":"L Wu","year":"2015","unstructured":"Wu, L. et al. An integrated system for identifying the hidden assassins in traditional medicines containing aristolochic acids. Sci. Rep. 5, 11318 (2015).","journal-title":"Sci. Rep."},{"key":"494_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/jcpt.12789","volume":"44","author":"HM Zhang","year":"2019","unstructured":"Zhang, H. M. et al. Recognition of the toxicity of aristolochic acid. J. Clin. Pharm. Ther. 44, 157\u2013162 (2019).","journal-title":"J. Clin. Pharm. Ther."},{"key":"494_CR16","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1080\/19440049.2014.892215","volume":"31","author":"L Vaclavik","year":"2014","unstructured":"Vaclavik, L., Krynitsky, A. J. & Rader, J. I. Quantification of aristolochic acids I and II in herbal dietary supplements by ultra-high-performance liquid chromatography\u2013multistage fragmentation mass spectrometry. Food Addit. Contam. Part. A Chem. Anal. Control. Expo. Risk Assess. 31, 784\u2013791 (2014).","journal-title":"Food Addit. Contam. Part. A Chem. Anal. Control. Expo. Risk Assess."},{"key":"494_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jep.2004.06.010","volume":"94","author":"BT Schaneberg","year":"2004","unstructured":"Schaneberg, B. T. & Khan, I. A. Analysis of products suspected of containing Aristolochia or Asarum species. J. Ethnopharmacol. 94, 245\u2013249 (2004).","journal-title":"J. Ethnopharmacol."},{"key":"494_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2016.02.013","author":"X Cachet","year":"2016","unstructured":"Cachet, X. et al. Detection of aristolochic acids I and II in \u201cChiniy-tr\u00e8f\u201d, a traditional medicinal preparation containing caterpillars feeding on Aristolochia trilobata L. in Martinique, French West Indies. Toxicon https:\/\/doi.org\/10.1016\/j.toxicon.2016.02.013 (2016).","journal-title":"Toxicon"},{"key":"494_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.toxicon.2019.10.241","volume":"172","author":"L Riffault-Valois","year":"2019","unstructured":"Riffault-Valois, L. et al. Health risk associated with the oral consumption of \u201cChiniy-tref\u201d, a traditional medicinal preparation used in Martinique (French West Indies): qualitative and quantitative analyses of aristolochic acids contained therein. Toxicon 172, 53\u201360 (2019).","journal-title":"Toxicon"},{"key":"494_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0278-6915(02)00219-3","volume":"41","author":"JR Ioset","year":"2003","unstructured":"Ioset, J. R., Raoelison, G. E. & Hostettmann, K. Detection of aristolochic acid in Chinese phytomedicines and dietary supplements used as slimming regimens. Food Chem. Toxicol. 41, 29\u201336 (2003).","journal-title":"Food Chem. Toxicol."},{"key":"494_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/15563650600671712","volume":"44","author":"TP Cheung","year":"2006","unstructured":"Cheung, T. P., Xue, C., Leung, K., Chan, K. & Li, C. G. Aristolochic acids detected in some raw Chinese medicinal herbs and manufactured herbal products \u2014 a consequence of inappropriate nomenclature and imprecise labelling? Clin. Toxicol. 44, 371\u2013378 (2006).","journal-title":"Clin. Toxicol."},{"key":"494_CR22","first-page":"135","volume":"34","author":"R Abdullah","year":"2017","unstructured":"Abdullah, R., Diaz, L. N., Wesseling, S. & Rietjens, I. M. C. M. Risk assessment of plant food supplements and other herbal products containing aristolochic acids using the margin of exposure (MOE) approach. Food Addit. Contam. Part. A 34, 135\u2013144 (2017).","journal-title":"Food Addit. Contam. Part. A"},{"key":"494_CR23","first-page":"8823596","volume":"2020","author":"J Liu","year":"2020","unstructured":"Liu, J., Liu, Y., Wu, Y., Dai, Z. & Ma, S. Rapid analysis of aristolochic acid analogues in traditional Chinese patent medicine by LC-MS\/MS. J. Anal. Methods Chem. Anal. Control Expo. Risk Assess. 2020, 8823596 (2020).","journal-title":"J. Anal. Methods Chem. Anal. Control Expo. Risk Assess."},{"key":"494_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jep.2013.06.028","volume":"149","author":"J Michl","year":"2013","unstructured":"Michl, J. et al. Is aristolochic acid nephropathy a widespread problem in developing countries?: a case study of Aristolochia indica L. in Bangladesh using an ethnobotanical\u2013phytochemical approach. J. Ethnopharmacol. 149, 235\u2013244 (2013).","journal-title":"J. Ethnopharmacol."},{"key":"494_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s11739-018-1813-2","volume":"13","author":"V Maggini","year":"2018","unstructured":"Maggini, V., Menniti-Ippolito, F. & Firenzuoli, F. Aristolochia, a nephrotoxic herb, still surfs on the Web, 15 years later. Intern. Emerg. Med. 13, 811\u2013813 (2018).","journal-title":"Intern. Emerg. Med."},{"key":"494_CR26","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1124\/dmd.107.014688","volume":"35","author":"S Shibutani","year":"2007","unstructured":"Shibutani, S. et al. Selective toxicity of aristolochic acids I and II. Drug Metab. Dispos. 35, 1217\u20131222 (2007).","journal-title":"Drug Metab. Dispos."},{"key":"494_CR27","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2019.03.001","volume":"177","author":"JE Kucab","year":"2019","unstructured":"Kucab, J. E. et al. A compendium of mutational signatures of environmental agents. Cell 177, 821\u2013836.e16 (2019).","journal-title":"Cell"},{"key":"494_CR28","first-page":"12","volume":"10","author":"S Wu","year":"1964","unstructured":"Wu, S. Two cases of acute renal failure caused by mutong. Jiang Xi Zhong Yi 10, 12\u201314 (1964).","journal-title":"Jiang Xi Zhong Yi"},{"key":"494_CR29","first-page":"32","volume":"8","author":"Y Hong","year":"1965","unstructured":"Hong, Y., Huang, Y. & Wang, Y. Over-dose of mutong causes renal failure and death. Zhe Jiang Zhong Yi Za Zhi 8, 32 (1965).","journal-title":"Zhe Jiang Zhong Yi Za Zhi"},{"key":"494_CR30","first-page":"223","volume":"4","author":"F Zhou","year":"1988","unstructured":"Zhou, F., Lu, H. & Nie, C. Toxicity of mutong causes acute renal failure. Zhonghua Shenzanbing Za Zhi 4, 223\u2013224 (1988).","journal-title":"Zhonghua Shenzanbing Za Zhi"},{"key":"494_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1561-5413(07)60003-9","volume":"9","author":"W-T Poon","year":"2007","unstructured":"Poon, W.-T., Lai, C.-K. & Chan, A. Y.-W. Aristolochic acid nephropathy: the Hong Kong perspective. Hong. Kong J. Nephrol. 9, 7\u201314 (2007).","journal-title":"Hong. Kong J. Nephrol."},{"key":"494_CR32","first-page":"35","volume":"42","author":"L Jackson","year":"1964","unstructured":"Jackson, L., Kofman, S., Weiss, A. & Brodovsky, H. Aristolochic acid (Nsc-50413): phase I clinical study. Cancer Chemother. Rep. 42, 35\u201337 (1964).","journal-title":"Cancer Chemother. Rep."},{"key":"494_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1021\/jm01238a029","volume":"91","author":"SM Kupchan","year":"1962","unstructured":"Kupchan, S. M. & Doskotch, R. W. Tumor inhibitors. I. Aristolochic acid, the active principle of Aristolochia indica. J. Med. Pharm. Chem. 91, 657\u2013659 (1962).","journal-title":"J. Med. Pharm. Chem."},{"key":"494_CR34","first-page":"1273","volume":"91","author":"M Ivi\u0107","year":"1969","unstructured":"Ivi\u0107, M. Etiology of endemic nephropathy. Lijec. Vjesn. 91, 1273\u20131281 (1969).","journal-title":"Lijec. Vjesn."},{"key":"494_CR35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0140-6736(93)92984-2","volume":"341","author":"J-L Vanherweghem","year":"1993","unstructured":"Vanherweghem, J.-L. et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 341, 387\u2013391 (1993).","journal-title":"Lancet"},{"key":"494_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/acm.1998.4.1-9","volume":"4","author":"J-L Vanherweghem","year":"1998","unstructured":"Vanherweghem, J.-L. Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J. Altern. Complement. Med. 4, 9\u201313 (1998).","journal-title":"J. Altern. Complement. Med."},{"key":"494_CR37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0272-6386(12)80178-8","volume":"24","author":"M Depierreux","year":"1994","unstructured":"Depierreux, M., Van Damme, B., Houte, K. V. & Vanherweghem, J. L. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am. J. Kidney Dis. 24, 172\u2013180 (1994).","journal-title":"Am. J. Kidney Dis."},{"key":"494_CR38","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/ki.1994.220","volume":"45","author":"JP Cosyns","year":"1994","unstructured":"Cosyns, J. P. et al. Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int. 45, 1680\u20131688 (1994). The authors examine the renal cortex specimens from individuals affected by the Belgian outbreak of AAN and report the first link connecting AAN to endemic nephropathy.","journal-title":"Kidney Int."},{"key":"494_CR39","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1056\/NEJM200006083422301","volume":"342","author":"JL Nortier","year":"2000","unstructured":"Nortier, J. L. et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N. Engl. J. Med. 342, 1686\u20131692 (2000). This study reports that patients with AAN face a high risk of developing urothelial carcinoma.","journal-title":"N. Engl. J. Med."},{"key":"494_CR40","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0272-6386(99)70136-8","volume":"33","author":"J-P Cosyns","year":"1999","unstructured":"Cosyns, J.-P., Jadoul, M., Squifflet, J.-P., Wese, F.-X. & van Ypersele de Strihou, C. Urothelial lesions in Chinese-herb nephropathy. Am. J. Kidney Dis. 33, 1011\u20131017 (1999).","journal-title":"Am. J. Kidney Dis."},{"key":"494_CR41","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1053\/j.ajkd.2007.11.015","volume":"51","author":"A Lemy","year":"2008","unstructured":"Lemy, A. et al. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up. Am. J. Kidney Dis. 51, 471\u2013477 (2008).","journal-title":"Am. J. Kidney Dis."},{"key":"494_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3109\/0886022X.2014.990347","volume":"37","author":"M Sun","year":"2015","unstructured":"Sun, M. et al. Analysis of potential risk factors for cancer incidence in patients with aristolochic acid nephropathy from Wenzhou, China. Ren. Fail. 37, 209\u2013213 (2015).","journal-title":"Ren. Fail."},{"key":"494_CR43","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0272-6386(00)70343-X","volume":"35","author":"C-S Yang","year":"2000","unstructured":"Yang, C.-S., Lin, C.-H., Chang, S.-H. & Hsu, H.-C. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am. J. Kidney Dis. 35, 313\u2013318 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"494_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1191\/0960327105ht502oa","volume":"24","author":"Y Wu","year":"2005","unstructured":"Wu, Y., Liu, Z., Hu, W. & Li, L. Mast cell infiltration associated with tubulointerstitial fibrosis in chronic aristolochic acid nephropathy. Hum. Exp. Toxicol. 24, 41\u201347 (2005).","journal-title":"Hum. Exp. Toxicol."},{"key":"494_CR45","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1053\/j.ajkd.2012.12.027","volume":"61","author":"J Zhang","year":"2013","unstructured":"Zhang, J., Zhang, L., Wang, W. & Wang, H. Association between aristolochic acid and CKD: a cross-sectional survey in China. Am. J. Kidney Dis. 61, 918\u2013922 (2013).","journal-title":"Am. J. Kidney Dis."},{"key":"494_CR46","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/ndt\/11.7.1359","volume":"11","author":"JM Pena","year":"1996","unstructured":"Pena, J. M., Borras, M., Ramos, J. & Montoliu, J. Rapidly progressive interstitial renal fibrosis due to a chronic intake of a herb (Aristolochia pistolochia) infusion. Nephrol. Dial. Transpl. 11, 1359\u20131360 (1996).","journal-title":"Nephrol. Dial. Transpl."},{"key":"494_CR47","first-page":"15","volume":"19","author":"B Stengel","year":"1998","unstructured":"Stengel, B. & Jones, E. End-stage renal insufficiency associated with Chinese herbal consumption in France [French]. Nephrologie 19, 15\u201320 (1998).","journal-title":"Nephrologie"},{"key":"494_CR48","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/ndt\/16.2.400","volume":"16","author":"B Krumme","year":"2001","unstructured":"Krumme, B., Endmeir, R., Vanhaelen, M. & Walb, D. Reversible Fanconi syndrome after ingestion of a Chinese herbal \u2018remedy\u2019 containing aristolochic acid. Nephrol. Dial. Transpl. 16, 400\u2013402 (2001).","journal-title":"Nephrol. Dial. Transpl."},{"key":"494_CR49","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10157-004-0296-9","volume":"8","author":"I Kazama","year":"2004","unstructured":"Kazama, I. et al. Adult onset Fanconi syndrome: extensive tubulo-interstitial lesions and glomerulopathy in the early stage of Chinese herbs nephropathy. Clin. Exp. Nephrol. 8, 283\u2013287 (2004).","journal-title":"Clin. Exp. Nephrol."},{"key":"494_CR50","first-page":"334","volume":"13","author":"MM Meyer","year":"2000","unstructured":"Meyer, M. M., Chen, T. P. & Bennett, W. M. Chinese herb nephropathy. Proc. (Bayl. Univ. Med. Cent.) 13, 334\u2013337 (2000).","journal-title":"Proc. (Bayl. Univ. Med. Cent.)"},{"key":"494_CR51","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1440-1797.2003.00232.x","volume":"9","author":"S Lee","year":"2004","unstructured":"Lee, S. et al. Fanconi\u2019s syndrome and subsequent progressive renal failure caused by a Chinese herb containing aristolochic acid. Nephrology 9, 126\u2013129 (2004).","journal-title":"Nephrology"},{"key":"494_CR52","first-page":"2025","volume":"56","author":"HH Schmeiser","year":"1996","unstructured":"Schmeiser, H. H., Bieler, C. A., Wiessler, M., de Strihou, C. V. Y. & Cosyns, J.-P. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res. 56, 2025\u20132028 (1996). This study establishes the presence of AL\u2013DNA adducts in renal tissue obtained from patients of the Belgian outbreak of AAN, implicating AA as the agent responsible for the observed nephropathy.","journal-title":"Cancer Res."},{"key":"494_CR53","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0940-2993(99)80033-5","volume":"51","author":"M Stiborov\u00e1","year":"1999","unstructured":"Stiborov\u00e1, M., Frei, E., Breuer, A., Bieler, C. A. & Schmeiser, H. H. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy. Exp. Toxicol. Pathol. 51, 421\u2013427 (1999).","journal-title":"Exp. Toxicol. Pathol."},{"key":"494_CR54","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/S0140-6736(01)06576-X","volume":"358","author":"GM Lord","year":"2001","unstructured":"Lord, G. M. et al. Urothelial malignant disease and Chinese herbal nephropathy. Lancet 358, 1515\u20131516 (2001).","journal-title":"Lancet"},{"key":"494_CR55","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/carcin\/18.5.1063","volume":"18","author":"CA Bieler","year":"1997","unstructured":"Bieler, C. A. et al. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. Carcinogenesis 18, 1063\u20131067 (1997).","journal-title":"Carcinogenesis"},{"key":"494_CR56","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1053\/j.ajkd.2004.09.019","volume":"45","author":"SH Lo","year":"2005","unstructured":"Lo, S. H. et al. Detection of Herba Aristolochia Mollissemae in a patient with unexplained nephropathy. Am. J. Kidney Dis. 45, 407\u2013410 (2005).","journal-title":"Am. J. Kidney Dis."},{"key":"494_CR57","doi-asserted-by":"publisher","first-page":"8241","DOI":"10.1073\/pnas.1119920109","volume":"109","author":"C-H Chen","year":"2012","unstructured":"Chen, C.-H. et al. Aristolochic acid-associated urothelial cancer in Taiwan. Proc. Natl Acad. Sci. USA 109, 8241\u20138246 (2012). This breakthrough molecular epidemiology study in East Asia establishes the significant contribution of exposure to AA to the high incidence of UTUC, using the characteristic molecular markers of exposure and its impact.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"494_CR58","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1021\/tx3000889","volume":"25","author":"BH Yun","year":"2012","unstructured":"Yun, B. H. et al. Biomonitoring of aristolactam\u2013DNA adducts in human tissues using ultra-performance liquid chromatography\/ion-trap mass spectrometry. Chem. Res. Toxicol. 25, 1119\u20131131 (2012).","journal-title":"Chem. Res. Toxicol."},{"key":"494_CR59","doi-asserted-by":"publisher","first-page":"e18.11","DOI":"10.1053\/j.ajkd.2003.11.024","volume":"43","author":"GM Lord","year":"2004","unstructured":"Lord, G. M. et al. DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy. Am. J. Kidney Dis. 43, e18.11\u2013e18.17 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"494_CR60","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1046\/j.1523-1755.2001.00034.x","volume":"60","author":"HY Chen","year":"2001","unstructured":"Chen, H. Y., Ma, B.-Y., Grant, A. & Lampert, N. Time to abandon the term \u201cChinese herbs nephropathy\u201d. Kidney Int. 60, 2039\u20132040 (2001).","journal-title":"Kidney Int."},{"key":"494_CR61","doi-asserted-by":"publisher","first-page":"E26","DOI":"10.1053\/ajkd.2001.28624","volume":"38","author":"G Gillerot","year":"2001","unstructured":"Gillerot, G. et al. Aristolochic acid nephropathy in a Chinese patient: time to abandon the term \u201cChinese herbs nephropathy\u201d? Am. J. Kidney Dis. 38, E26 (2001).","journal-title":"Am. J. Kidney Dis."},{"key":"494_CR62","doi-asserted-by":"publisher","first-page":"12129","DOI":"10.1073\/pnas.0701248104","volume":"104","author":"AP Grollman","year":"2007","unstructured":"Grollman, A. P. et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl Acad. Sci. USA 104, 12129 (2007). This molecular epidemiology study establishes dietary exposure to AA from environmental sources as a significant risk factor for BEN and associated urothelial carcinomas.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"494_CR63","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/ki.2011.371","volume":"81","author":"B Jelakovi\u0107","year":"2012","unstructured":"Jelakovi\u0107, B. et al. Aristolactam\u2013DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int. 81, 559\u2013567 (2012). This work describes the occurrence of AL\u2013DNA adducts and the TP53 AA mutational spectrum in the UTUC of patients who resided in the endemic region.","journal-title":"Kidney Int."},{"key":"494_CR64","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/ijc.10602","volume":"101","author":"VM Arlt","year":"2002","unstructured":"Arlt, V. M. et al. Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer? Int. J. Cancer 101, 500\u2013502 (2002).","journal-title":"Int. J. Cancer"},{"key":"494_CR65","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/sj.ki.5000231","volume":"69","author":"V Batuman","year":"2006","unstructured":"Batuman, V. Fifty years of Balkan endemic nephropathy: daunting questions, elusive answers. Kidney Int. 69, 644\u2013646 (2006).","journal-title":"Kidney Int."},{"key":"494_CR66","first-page":"116","volume":"46","author":"T Hranjec","year":"2005","unstructured":"Hranjec, T. et al. Endemic nephropathy: the case for chronic poisoning by Aristolochia. Croat. Med. J. 46, 116\u2013125 (2005).","journal-title":"Croat. Med. J."},{"key":"494_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1749-8546-3-13","volume":"3","author":"S-C Hsieh","year":"2008","unstructured":"Hsieh, S.-C., Lin, I.-H., Tseng, W.-L., Lee, C.-H. & Wang, J.-D. Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003. Chin. Med. 3, 1\u20136 (2008).","journal-title":"Chin. Med."},{"key":"494_CR68","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1053\/j.ajkd.2009.10.055","volume":"55","author":"M-N Lai","year":"2010","unstructured":"Lai, M.-N. et al. Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: a population-based case\u2013control study. Am. J. Kidney Dis. 55, 507\u2013518 (2010).","journal-title":"Am. J. Kidney Dis."},{"key":"494_CR69","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/jnci\/djp467","volume":"102","author":"M-N Lai","year":"2010","unstructured":"Lai, M.-N., Wang, S.-M., Chen, P.-C., Chen, Y.-Y. & Wang, J.-D. Population-based case\u2013control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J. Natl Cancer Inst. 102, 179\u2013186 (2010). This case\u2013control study examines the association between prescription of AA-containing herbal products and urinary tract cancer in Taiwan, reporting that consumption of AA-containing herbal products is associated with an increased risk of urinary tract cancer.","journal-title":"J. Natl Cancer Inst."},{"key":"494_CR70","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1158\/1055-9965.EPI-16-0219","volume":"25","author":"ML Hoang","year":"2016","unstructured":"Hoang, M. L. et al. Aristolochic acid in the etiology of renal cell carcinoma. Cancer Epidemiol. Prev. Biomark. 25, 1600\u20131608 (2016).","journal-title":"Cancer Epidemiol. Prev. Biomark."},{"key":"494_CR71","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2188\/jea.JE20080035","volume":"19","author":"H-y Yang","year":"2009","unstructured":"Yang, H.-y, Wang, J.-D., Lo, T.-C. & Chen, P.-C. Increased mortality risk for cancers of the kidney and other urinary organs among Chinese herbalists. J. Epidemiol. Jpn. Epidemiol. Assoc. 19, 17\u201323 (2009).","journal-title":"J. Epidemiol. Jpn. Epidemiol. Assoc."},{"key":"494_CR72","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0929-6646(11)60026-0","volume":"110","author":"H-Y Yang","year":"2011","unstructured":"Yang, H.-Y., Wang, J.-D., Lo, T.-C. & Chen, P.-C. Increased risks of upper tract urothelial carcinoma in male and female Chinese herbalists. J. Formos. Med. Assoc. 110, 161\u2013168 (2011). This study reports that herbalists in Taiwan had a significantly higher risk of developing upper tract urothelial, renal and bladder cancers.","journal-title":"J. Formos. Med. Assoc."},{"key":"494_CR73","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1136\/oem.2010.058594","volume":"68","author":"H-Y Yang","year":"2011","unstructured":"Yang, H.-Y., Wang, J.-D., Lo, T.-C. & Chen, P.-C. Occupational kidney disease among Chinese herbalists exposed to herbs containing aristolochic acids. Occup. Environ. Med. 68, 286\u2013290 (2011).","journal-title":"Occup. Environ. Med."},{"key":"494_CR74","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.juro.2012.08.090","volume":"189","author":"H-Y Yang","year":"2013","unstructured":"Yang, H.-Y., Wang, J.-D., Lo, T.-C. & Chen, P.-C. Occupational exposure to herbs containing aristolochic acids increases the risk of urothelial carcinoma in Chinese herbalists. J. Urol. 189, 48\u201352 (2013). Following up on a previous study (ref. 73), the authors determine that having processed, sold or dispensed herbs containing fangchi significantly increases the risk of developing urothelial carcinoma in Chinese herbalists.","journal-title":"J. Urol."},{"key":"494_CR75","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/ijc.31544","volume":"143","author":"C-J Chen","year":"2018","unstructured":"Chen, C.-J. et al. Herbal medicine containing aristolochic acid and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection. Int. J. Cancer 143, 1578\u20131587 (2018). This study reports a significant dose\u2013response relationship between the consumption of AA-containing herbs and the risk of developing HCC among patients infected with HBV.","journal-title":"Int. J. Cancer"},{"key":"494_CR76","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1158\/1055-9965.EPI-19-0023","volume":"28","author":"CJ Chen","year":"2019","unstructured":"Chen, C. J. et al. Herbal medicine containing aristolochic acid and the risk of primary liver cancer in patients with hepatitis C virus infection. Cancer Epidemiol. Biomark. Prev. 28, 1876\u20131883 (2019). This study reports a significant dose\u2013response relationship between the consumption of AA-containing herbs and the risk of developing primary liver cancers among patients infected with HCV.","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"494_CR77","doi-asserted-by":"publisher","first-page":"154023","DOI":"10.1016\/j.phymed.2022.154023","volume":"99","author":"CJ Chen","year":"2022","unstructured":"Chen, C. J. et al. Aristolochic acid and the risk of cancers in patients with type 2 diabetes: nationwide population-based cohort study. Phytomedicine 99, 154023 (2022). This study reports that the use of AA-containing herbs is associated with a significantly higher risk of developing liver, colorectum, kidney, bladder, prostate, pelvis and ureter cancers in patients with diabetes.","journal-title":"Phytomedicine"},{"key":"494_CR78","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mrrev.2013.02.003","volume":"753","author":"M Hollstein","year":"2013","unstructured":"Hollstein, M., Moriya, M., Grollman, A. P. & Olivier, M. Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid. Mutat. Res. 753, 41\u201349 (2013).","journal-title":"Mutat. Res."},{"key":"494_CR79","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/BF00293699","volume":"61","author":"U Mengs","year":"1988","unstructured":"Mengs, U. Tumour induction in mice following exposure to aristolochic acid. Arch. Toxicol. 61, 504\u2013505 (1988).","journal-title":"Arch. Toxicol."},{"key":"494_CR80","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/BF00302751","volume":"51","author":"U Mengs","year":"1982","unstructured":"Mengs, U., Lang, W. & Poch, J. A. The carcinogenic action of aristolochic acid in rats. Arch. Toxicol. 51, 107\u2013119 (1982).","journal-title":"Arch. Toxicol."},{"key":"494_CR81","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/BF00333900","volume":"52","author":"U Mengs","year":"1983","unstructured":"Mengs, U. On the histopathogenesis of rat forestomach carcinoma caused by aristolochic acid. Arch. Toxicol. 52, 209\u2013220 (1983).","journal-title":"Arch. Toxicol."},{"key":"494_CR82","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1080\/15287390600747965","volume":"69","author":"MS Hwang","year":"2006","unstructured":"Hwang, M. S. et al. Subchronic toxicity studies of the aqueous extract of Aristolochiae fructus in Sprague-Dawley rats. J. Toxicol. Env. Health A 69, 2157\u20132165 (2006).","journal-title":"J. Toxicol. Env. Health A"},{"key":"494_CR83","first-page":"5464","volume":"50","author":"HH Schmeiser","year":"1990","unstructured":"Schmeiser, H. H. et al. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues. Cancer Res. 50, 5464\u20135469 (1990).","journal-title":"Cancer Res."},{"key":"494_CR84","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/hep.30863","volume":"71","author":"ZN Lu","year":"2020","unstructured":"Lu, Z. N. et al. The mutational features of aristolochic acid\u2013induced mouse and human liver cancers. Hepatology 71, 929\u2013942 (2020).","journal-title":"Hepatology"},{"key":"494_CR85","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/ijms18020297","volume":"18","author":"I Jadot","year":"2017","unstructured":"Jadot, I., Decl\u00e8ves, A.-E., Nortier, J. & Caron, N. An integrated view of aristolochic acid nephropathy: update of the literature. Int. J. Mol. Sci. 18, 297 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"494_CR86","first-page":"45","volume":"12","author":"National Toxicology Program.","year":"2011","unstructured":"National Toxicology Program. Aristolochic acids. Rep. Carcinog. 12, 45\u201349 (2011).","journal-title":"Rep. Carcinog."},{"key":"494_CR87","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.95978","author":"SY Chang","year":"2017","unstructured":"Chang, S. Y. et al. Human liver\u2013kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.95978 (2017).","journal-title":"JCI Insight"},{"key":"494_CR88","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/carcin\/bgw045","volume":"37","author":"K Hashimoto","year":"2016","unstructured":"Hashimoto, K. et al. Sulfotransferase-1A1-dependent bioactivation of aristolochic acid I and N-hydroxyaristolactam I in human cells. Carcinogenesis 37, 647\u2013655 (2016).","journal-title":"Carcinogenesis"},{"key":"494_CR89","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-3-030-41283-8_9","volume":"1241","author":"VS Sidorenko","year":"2020","unstructured":"Sidorenko, V. S. Biotransformation and toxicities of aristolochic acids. Adv. Exp. Med. Biol. 1241, 139\u2013166 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"494_CR90","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1093\/carcin\/bgu095","volume":"35","author":"VS Sidorenko","year":"2014","unstructured":"Sidorenko, V. S. et al. Bioactivation of the human carcinogen aristolochic acid. Carcinogenesis 35, 1814\u20131822 (2014).","journal-title":"Carcinogenesis"},{"key":"494_CR91","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2174\/1389200211314060006","volume":"14","author":"M Stiborova","year":"2013","unstructured":"Stiborova, M., Martinek, V., Frei, E., Arlt, V. M. & Schmeiser, H. H. Enzymes metabolizing aristolochic acid and their contribution to the development of aristolochic acid nephropathy and urothelial cancer. Curr. Drug Metab. 14, 695\u2013705 (2013).","journal-title":"Curr. Drug Metab."},{"key":"494_CR92","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/em.22321","volume":"60","author":"Y Okuno","year":"2019","unstructured":"Okuno, Y. et al. Bioactivation mechanisms of N-hydroxyaristolactams: nitroreduction metabolites of aristolochic acids. Environ. Mol. Mutagen. 60, 792\u2013806 (2019).","journal-title":"Environ. Mol. Mutagen."},{"key":"494_CR93","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s00204-016-1808-6","volume":"91","author":"VM Arlt","year":"2017","unstructured":"Arlt, V. M. et al. Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3-nitrobenzanthrone. Arch. Toxicol. 91, 1957\u20131975 (2017).","journal-title":"Arch. Toxicol."},{"key":"494_CR94","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/carcin\/11.2.313","volume":"11","author":"W Pfau","year":"1990","unstructured":"Pfau, W., Schmeiser, H. H. & Wiessler, M. Aristolochic acid binds covalently to the exocyclic amino group of purine nucleotides in DNA. Carcinogenesis 11, 313\u2013319 (1990).","journal-title":"Carcinogenesis"},{"key":"494_CR95","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/nar\/gkp815","volume":"38","author":"S Attaluri","year":"2010","unstructured":"Attaluri, S. et al. DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cells. Nucleic Acids Res. 38, 339\u2013352 (2010).","journal-title":"Nucleic Acids Res."},{"key":"494_CR96","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1093\/carcin\/15.10.2331","volume":"15","author":"TH Broschard","year":"1994","unstructured":"Broschard, T. H., Wiessler, M., von der Lieth, C.-W. & Schmeiser, H. H. Translesional synthesis on DNA templates containing site-specifically placed deoxyadenosine and deoxyguanosine adducts formed by the plant carcinogen aristolochic acid. Carcinogenesis 15, 2331\u20132340 (1994).","journal-title":"Carcinogenesis"},{"key":"494_CR97","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ijc.28681","volume":"135","author":"HH Schmeiser","year":"2014","unstructured":"Schmeiser, H. H. et al. Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy. Int. J. Cancer 135, 502\u2013507 (2014).","journal-title":"Int. J. Cancer"},{"key":"494_CR98","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1021\/acs.chemrestox.8b00359","volume":"32","author":"Y Liu","year":"2019","unstructured":"Liu, Y., Chan, C. K., Jin, L., Wong, S. K. & Chan, W. Quantitation of DNA adducts in target and nontarget organs of aristolochic acid I-exposed rats: correlating DNA adduct levels with organotropic activities. Chem. Res. Toxicol. 32, 397\u2013399 (2019).","journal-title":"Chem. Res. Toxicol."},{"key":"494_CR99","first-page":"167","volume":"124","author":"RC Fernando","year":"1993","unstructured":"Fernando, R. C., Schmeiser, H. H., Scherf, H. R. & Wiessler, M. Formation and persistence of specific purine DNA adducts by 32P-postlabelling in target and non-target organs of rats treated with aristolochic acid I. IARC Sci. Publ. 124, 167-171 (1993).","journal-title":"IARC Sci. Publ."},{"key":"494_CR100","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1093\/nar\/gkr1095","volume":"40","author":"VS Sidorenko","year":"2012","unstructured":"Sidorenko, V. S. et al. Lack of recognition by global-genome nucleotide excision repair accounts for the high mutagenicity and persistence of aristolactam\u2013DNA adducts. Nucleic Acids Res. 40, 2494\u20132505 (2012).","journal-title":"Nucleic Acids Res."},{"key":"494_CR101","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1093\/nar\/gkr1094","volume":"40","author":"M Lukin","year":"2012","unstructured":"Lukin, M., Zaliznyak, T., Johnson, F. & de los Santos, C. Structure and stability of DNA containing an aristolactam II\u2013dA lesion: implications for the NER recognition of bulky adducts. Nucleic Acids Res. 40, 2759\u20132770 (2012).","journal-title":"Nucleic Acids Res."},{"key":"494_CR102","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.dnarep.2016.07.003","volume":"46","author":"K Hashimoto","year":"2016","unstructured":"Hashimoto, K., Bonala, R., Johnson, F., Grollman, A. P. & Moriya, M. Y-family DNA polymerase-independent gap-filling translesion synthesis across aristolochic acid-derived adenine adducts in mouse cells. DNA Repair. 46, 55\u201360 (2016).","journal-title":"DNA Repair."},{"key":"494_CR103","doi-asserted-by":"publisher","first-page":"197ra101","DOI":"10.1126\/scitranslmed.3006086","volume":"5","author":"SL Poon","year":"2013","unstructured":"Poon, S. L. et al. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool. Sci. Transl. Med. 5, 197ra101\u2013197ra101 (2013). This study provides one of the first descriptions of the AA mutational signature on a genome-wide scale in mice and humans.","journal-title":"Sci. Transl. Med."},{"key":"494_CR104","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"494_CR105","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1002\/ijc.26077","volume":"129","author":"M Moriya","year":"2011","unstructured":"Moriya, M. et al. TP53 mutational signature for aristolochic acid: an environmental carcinogen. Int. J. Cancer 129, 1532\u20131536 (2011).","journal-title":"Int. J. Cancer"},{"key":"494_CR106","doi-asserted-by":"publisher","first-page":"197ra102","DOI":"10.1126\/scitranslmed.3006200","volume":"5","author":"ML Hoang","year":"2013","unstructured":"Hoang, M. L. et al. Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing. Sci. Transl. Med. 5, 197ra102\u2013197ra102 (2013). This study describes the AA mutational signature in UTUC in individuals with documented exposure to AA, illustrating the mutagenicity of AA in humans and providing one of the first descriptions of the AA mutational signature on a genome-wide scale.","journal-title":"Sci. Transl. Med."},{"key":"494_CR107","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.dnarep.2016.05.027","volume":"44","author":"TA Rosenquist","year":"2016","unstructured":"Rosenquist, T. A. & Grollman, A. P. Mutational signature of aristolochic acid: clue to the recognition of a global disease. DNA Repair. 44, 205\u2013211 (2016).","journal-title":"DNA Repair."},{"key":"494_CR108","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1158\/1055-9965.EPI-15-0553","volume":"24","author":"X Castells","year":"2015","unstructured":"Castells, X. et al. Low-coverage exome sequencing screen in formalin-fixed paraffin-embedded tumors reveals evidence of exposure to carcinogenic aristolochic acid. Cancer Epidemiol. Prev. Biomark. 24, 1873\u20131881 (2015). This study describes a protocol for conducting low-coverage whole-exome sequencing that can reliably detect the AA mutational signature, among other signatures, in archival FFPE urothelial tumours.","journal-title":"Cancer Epidemiol. Prev. Biomark."},{"key":"494_CR109","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.7150\/thno.43251","volume":"10","author":"H Lu","year":"2020","unstructured":"Lu, H. et al. Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma. Theranostics 10, 4323\u20134333 (2020). The authors conduct whole-genome sequencing on 90 upper tract urothelial cancers from patients residing in China that were not preselected for documented AA consumption, and report that 27 harboured the AA mutational signature and that the mutational signature may be detected in urinary cell-free DNA.","journal-title":"Theranostics"},{"key":"494_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-015-0161-3","volume":"7","author":"SL Poon","year":"2015","unstructured":"Poon, S. L. et al. Mutation signatures implicate aristolochic acid in bladder cancer development. Genome Med. 7, 1\u201310 (2015).","journal-title":"Genome Med."},{"key":"494_CR111","doi-asserted-by":"publisher","first-page":"828314","DOI":"10.3389\/fonc.2021.828314","volume":"11","author":"H-Y Lai","year":"2022","unstructured":"Lai, H.-Y. et al. High level of aristolochic acid detected with a unique genomic landscape predicts early UTUC onset after renal transplantation in Taiwan. Front. Oncol. 11, 828314\u2013828314 (2022).","journal-title":"Front. Oncol."},{"key":"494_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms6135","volume":"5","author":"G Scelo","year":"2014","unstructured":"Scelo, G. et al. Variation in genomic landscape of clear cell renal cell carcinoma across Europe. Nat. Commun. 5, 1\u201313 (2014). This study presents whole-genome sequences of ccRCCs from four European countries, identifying the AA mutational signature in cancers originating from patients from Romania but outside the previously reported endemic region.","journal-title":"Nat. Commun."},{"key":"494_CR113","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/bjc.2015.402","volume":"114","author":"RJ Turesky","year":"2016","unstructured":"Turesky, R. J. et al. Aristolochic acid exposure in Romania and implications for renal cell carcinoma. Br. J. Cancer 114, 76\u201380 (2016). Following up on the earlier report by Scelo et al. (2014), the authors detect the AL\u2013DNA adduct in non-tumour renal tissue from the AA-associated Romanian RCC cases reported by Scelo et al., concluding that AA exposure occurs and is responsible for causing AA-associated diseases in Europe outside the previously reported endemic region.","journal-title":"Br. J. Cancer"},{"key":"494_CR114","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1002\/ijc.29338","volume":"136","author":"B Jelakovi\u0107","year":"2015","unstructured":"Jelakovi\u0107, B. et al. Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid. Int. J. Cancer 136, 2967\u20132972 (2015).","journal-title":"Int. J. Cancer"},{"key":"494_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01358-x","volume":"8","author":"E Letouz\u00e9","year":"2017","unstructured":"Letouz\u00e9, E. et al. Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis. Nat. Commun. 8, 1315 (2017).","journal-title":"Nat. Commun."},{"key":"494_CR116","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.7150\/thno.56539","volume":"11","author":"J Lin","year":"2021","unstructured":"Lin, J. et al. Mutational spectrum and precision oncology for biliary tract carcinoma. Theranostics 11, 4585\u20134598 (2021).","journal-title":"Theranostics"},{"key":"494_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6696","volume":"5","author":"S Zou","year":"2014","unstructured":"Zou, S. et al. Mutational landscape of intrahepatic cholangiocarcinoma. Nat. Commun. 5, 5696 (2014).","journal-title":"Nat. Commun."},{"key":"494_CR118","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/s41588-021-00928-6","volume":"53","author":"S Moody","year":"2021","unstructured":"Moody, S. et al. Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. Nat. Genet. 53, 1553\u20131563 (2021).","journal-title":"Nat. Genet."},{"key":"494_CR119","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41422-020-0333-6","volume":"30","author":"Y Cui","year":"2020","unstructured":"Cui, Y. et al. Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma. Cell Res. 30, 902\u2013913 (2020).","journal-title":"Cell Res."},{"key":"494_CR120","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.eururo.2016.09.046","volume":"71","author":"Y Du","year":"2017","unstructured":"Du, Y. et al. Mutagenic factors and complex clonal relationship of multifocal urothelial cell carcinoma. Eur. Urol. 71, 841\u2013843 (2017).","journal-title":"Eur. Urol."},{"key":"494_CR121","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/ng.2798","volume":"45","author":"G Guo","year":"2013","unstructured":"Guo, G. et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat. Genet. 45, 1459\u20131463 (2013).","journal-title":"Nat. Genet."},{"key":"494_CR122","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","author":"Cancer Genome Atlas Research Network.","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315\u2013322 (2014).","journal-title":"Nature"},{"key":"494_CR123","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1126\/science.aba7300","volume":"370","author":"R Li","year":"2020","unstructured":"Li, R. et al. Macroscopic somatic clonal expansion in morphologically normal human urothelium. Science 370, 82\u201389 (2020).","journal-title":"Science"},{"key":"494_CR124","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1126\/science.aba8347","volume":"370","author":"ARJ Lawson","year":"2020","unstructured":"Lawson, A. R. J. et al. Extensive heterogeneity in somatic mutation and selection in the human bladder. Science 370, 75\u201382 (2020).","journal-title":"Science"},{"key":"494_CR125","doi-asserted-by":"publisher","first-page":"9846","DOI":"10.1073\/pnas.1607794113","volume":"113","author":"ML Hoang","year":"2016","unstructured":"Hoang, M. L. et al. Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing. Proc. Natl Acad. Sci. USA 113, 9846 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"494_CR126","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ng.2295","volume":"44","author":"WK Sung","year":"2012","unstructured":"Sung, W. K. et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat. Genet. 44, 765\u2013769 (2012).","journal-title":"Nat. Genet."},{"key":"494_CR127","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","volume":"169","author":"Cancer Genome Atlas Research Network.","year":"2017","unstructured":"Cancer Genome Atlas Research Network. Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell 169, 1327\u20131341.e23 (2017).","journal-title":"Cell"},{"key":"494_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18186-1","volume":"11","author":"J Candia","year":"2020","unstructured":"Candia, J. et al. The genomic landscape of Mongolian hepatocellular carcinoma. Nat. Commun. 11, 4383 (2020).","journal-title":"Nat. Commun."},{"key":"494_CR129","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41586-021-03836-1","volume":"597","author":"R Li","year":"2021","unstructured":"Li, R. et al. A body map of somatic mutagenesis in morphologically normal human tissues. Nature 597, 398\u2013403 (2021).","journal-title":"Nature"},{"key":"494_CR130","doi-asserted-by":"publisher","first-page":"nwab192","DOI":"10.1093\/nsr\/nwab192","volume":"9","author":"W Zhai","year":"2021","unstructured":"Zhai, W. et al. Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study. Nat. Sci. Rev. 9, nwab192 (2021).","journal-title":"Nat. Sci. Rev."},{"key":"494_CR131","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3390\/cancers14030576","volume":"14","author":"AH Lim","year":"2022","unstructured":"Lim, A. H. et al. Rare occurrence of aristolochic acid mutational signatures in oro-gastrointestinal tract cancers. Cancers 14, 576 (2022).","journal-title":"Cancers"},{"key":"494_CR132","first-page":"763","volume":"30","author":"S Nik-Zainal","year":"2015","unstructured":"Nik-Zainal, S. et al. The genome as a record of environmental exposure. Mutagenesis 30, 763\u2013770 (2015).","journal-title":"Mutagenesis"},{"key":"494_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep04482","volume":"4","author":"M Olivier","year":"2014","unstructured":"Olivier, M. et al. Modelling mutational landscapes of human cancers in vitro. Sci. Rep. 4, 1\u20139 (2014).","journal-title":"Sci. Rep."},{"key":"494_CR134","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"494_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-018-0539-0","volume":"10","author":"F Blokzijl","year":"2018","unstructured":"Blokzijl, F., Janssen, R., van Boxtel, R. & Cuppen, E. MutationalPatterns: comprehensive genome-wide analysis of mutational processes. Genome Med. 10, 33 (2018).","journal-title":"Genome Med."},{"key":"494_CR136","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/978-1-0716-0810-4_28","volume":"2185","author":"SMA Islam","year":"2021","unstructured":"Islam, S. M. A. & Alexandrov, L. B. Bioinformatic methods to identify mutational signatures in cancer. Methods Mol. Biol. 2185, 447\u2013473 (2021).","journal-title":"Methods Mol. Biol."},{"key":"494_CR137","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl9283","author":"A Degasperi","year":"2022","unstructured":"Degasperi, A. et al. Substitution mutational signatures in whole-genome-sequenced cancers in the UK population. Science https:\/\/doi.org\/10.1126\/science.abl9283 (2022).","journal-title":"Science"},{"key":"494_CR138","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/ijc.33827","volume":"150","author":"S Karanovi\u0107","year":"2022","unstructured":"Karanovi\u0107, S. et al. Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure. Int. J. Cancer 150, 374\u2013386 (2022).","journal-title":"Int. J. Cancer"},{"key":"494_CR139","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1158\/1055-9965.EPI-20-1090","volume":"30","author":"C-H Chen","year":"2021","unstructured":"Chen, C.-H. et al. Additive effects of arsenic and aristolochic acid in chemical carcinogenesis of upper urinary tract urothelium. Cancer Epidemiol. Biomark. Prev. 30, 317 (2021).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"494_CR140","first-page":"1","volume":"30","author":"M Zhang","year":"2020","unstructured":"Zhang, M., Liu, H., Han, Y., Bai, L. & Yan, H. A review on the pharmacological properties, toxicological characteristics, pathogenic mechanism and analytical methods of aristolochic acids. Toxin Rev. 30, 1\u201310 (2020).","journal-title":"Toxin Rev."},{"key":"494_CR141","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.chroma.2007.06.055","volume":"1164","author":"W Chan","year":"2007","unstructured":"Chan, W., Lee, K.-C., Liu, N. & Cai, Z. A sensitivity enhanced high-performance liquid chromatography fluorescence method for the detection of nephrotoxic and carcinogenic aristolochic acid in herbal medicines. J. Chromatogr. A 1164, 113\u2013119 (2007).","journal-title":"J. Chromatogr. A"},{"key":"494_CR142","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s40264-015-0306-8","volume":"38","author":"HJ de Boer","year":"2015","unstructured":"de Boer, H. J., Ichim, M. C. & Newmaster, S. G. DNA barcoding and pharmacovigilance of herbal medicines. Drug Saf. 38, 611\u2013620 (2015).","journal-title":"Drug Saf."},{"key":"494_CR143","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.foodchem.2013.09.146","volume":"147","author":"M Li","year":"2014","unstructured":"Li, M. et al. Molecular identification and cytotoxicity study of herbal medicinal materials that are confused by Aristolochia herbs. Food Chem. 147, 332\u2013339 (2014).","journal-title":"Food Chem."},{"key":"494_CR144","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3389\/fpls.2018.01828","volume":"9","author":"T Sgamma","year":"2018","unstructured":"Sgamma, T., Masiero, E., Mali, P., Mahat, M. & Slater, A. Sequence-specific detection of Aristolochia DNA \u2014 a simple test for contamination of herbal products. Front. Plant Sci. 9, 1828\u20131828 (2018).","journal-title":"Front. Plant Sci."},{"key":"494_CR145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202625","volume":"13","author":"P Dechbumroong","year":"2018","unstructured":"Dechbumroong, P., Aumnouypol, S., Denduangboripant, J. & Sukrong, S. DNA barcoding of Aristolochia plants and development of species-specific multiplex PCR to aid HPTLC in ascertainment of Aristolochia herbal materials. PloS ONE 13, e0202625 (2018).","journal-title":"PloS ONE"},{"key":"494_CR146","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3389\/fpls.2016.00887","volume":"7","author":"L Wu","year":"2016","unstructured":"Wu, L. et al. Rapid identification of officinal Akebiae Caulis and its toxic adulterant Aristolochiae Manshuriensis Caulis (Aristolochia manshuriensis) by loop-mediated isothermal amplification. Front. Plant. Sci. 7, 887\u2013887 (2016).","journal-title":"Front. Plant. Sci."},{"key":"494_CR147","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/pca.2732","volume":"29","author":"AC Raclariu","year":"2018","unstructured":"Raclariu, A. C., Heinrich, M., Ichim, M. C. & de Boer, H. Benefits and limitations of DNA barcoding and metabarcoding in herbal product authentication. Phytochem. Anal. 29, 123\u2013128 (2018).","journal-title":"Phytochem. Anal."},{"key":"494_CR148","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00414-010-0447-3","volume":"124","author":"I Bruni","year":"2010","unstructured":"Bruni, I. et al. Identification of poisonous plants by DNA barcoding approach. Int. J. Leg. Med. 124, 595\u2013603 (2010).","journal-title":"Int. J. Leg. Med."},{"key":"494_CR149","doi-asserted-by":"publisher","first-page":"9943","DOI":"10.1021\/acs.analchem.8b02170","volume":"90","author":"BH Yun","year":"2018","unstructured":"Yun, B. H., Bellamri, M., Rosenquist, T. A. & Turesky, R. J. Method for biomonitoring DNA adducts in exfoliated urinary cells by mass spectrometry. Anal. Chem. 90, 9943\u20139950 (2018).","journal-title":"Anal. Chem."},{"key":"494_CR150","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1021\/acs.analchem.6b00124","volume":"88","author":"J Guo","year":"2016","unstructured":"Guo, J. et al. Multiclass carcinogenic DNA adduct quantification in formalin-fixed paraffin-embedded tissues by ultraperformance liquid chromatography\u2013tandem mass spectrometry. Anal. Chem. 88, 4780\u20134787 (2016).","journal-title":"Anal. Chem."},{"key":"494_CR151","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1021\/ac400612x","volume":"85","author":"BH Yun","year":"2013","unstructured":"Yun, B. H. et al. Human formalin-fixed paraffin-embedded tissues: an untapped specimen for biomonitoring of carcinogen DNA adducts by mass spectrometry. Anal. Chem. 85, 4251\u20134258 (2013).","journal-title":"Anal. Chem."},{"key":"494_CR152","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/carcin\/bgu101","volume":"35","author":"BH Yun","year":"2014","unstructured":"Yun, B. H. et al. Formalin-fixed paraffin-embedded tissue as a source for quantitation of carcinogen DNA adducts: aristolochic acid as a prototype carcinogen. Carcinogenesis 35, 2055\u20132061 (2014).","journal-title":"Carcinogenesis"},{"key":"494_CR153","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-021-03477-4","volume":"593","author":"F Abascal","year":"2021","unstructured":"Abascal, F. et al. Somatic mutation landscapes at single-molecule resolution. Nature 593, 405\u2013410 (2021).","journal-title":"Nature"},{"key":"494_CR154","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1038\/nprot.2014.170","volume":"9","author":"SR Kennedy","year":"2014","unstructured":"Kennedy, S. R. et al. Detecting ultralow-frequency mutations by duplex sequencing. Nat. Protoc. 9, 2586\u20132606 (2014).","journal-title":"Nat. Protoc."},{"key":"494_CR155","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrg.2017.117","volume":"19","author":"JJ Salk","year":"2018","unstructured":"Salk, J. J., Schmitt, M. W. & Loeb, L. A. Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations. Nat. Rev. Genet. 19, 269\u2013285 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"494_CR156","doi-asserted-by":"publisher","first-page":"14508","DOI":"10.1073\/pnas.1208715109","volume":"109","author":"MW Schmitt","year":"2012","unstructured":"Schmitt, M. W. et al. Detection of ultra-rare mutations by next-generation sequencing. Proc. Natl Acad. Sci. USA 109, 14508\u201314513 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"494_CR157","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jchromb.2010.11.035","volume":"879","author":"L Guo","year":"2011","unstructured":"Guo, L. et al. A novel and specific method for the determination of aristolochic acid-derived DNA adducts in exfoliated urothelial cells by using ultra performance liquid chromatography\u2013triple quadrupole mass spectrometry. J. Chromatogr. B 879, 153\u2013158 (2011).","journal-title":"J. Chromatogr. B"},{"key":"494_CR158","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1039\/C5TX00052A","volume":"4","author":"BH Yun","year":"2015","unstructured":"Yun, B. H. et al. New approaches for biomonitoring exposure to the human carcinogen aristolochic acid. Toxicol. Res. 4, 763\u2013776 (2015).","journal-title":"Toxicol. Res."},{"key":"494_CR159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mrfmmm.2014.05.004","volume":"766\u2013767","author":"EMK Leung","year":"2014","unstructured":"Leung, E. M. K. & Chan, W. Noninvasive measurement of aristolochic acid\u2013DNA adducts in urine samples from aristolochic acid-treated rats by liquid chromatography coupled tandem mass spectrometry: evidence for DNA repair by nucleotide-excision repair mechanisms. Mutat. Res. Fund. Mol. Mech. Mutagen. 766\u2013767, 1\u20136 (2014).","journal-title":"Mutat. Res. Fund. Mol. Mech. Mutagen."},{"key":"494_CR160","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1021\/acs.chemrestox.5b00021","volume":"28","author":"EMK Leung","year":"2015","unstructured":"Leung, E. M. K. & Chan, W. Quantification of aristolochic acid\u2013RNA adducts in the urine of aristolochic acid-treated rats by liquid chromatography\u2013tandem mass spectrometry. Chem. Res. Toxicol. 28, 567\u2013569 (2015).","journal-title":"Chem. Res. Toxicol."},{"key":"494_CR161","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.32143","volume":"7","author":"SU Springer","year":"2018","unstructured":"Springer, S. U. et al. Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy. eLife 7, e32143 (2018).","journal-title":"eLife"},{"key":"494_CR162","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.dnarep.2018.08.003","volume":"71","author":"DH Phillips","year":"2018","unstructured":"Phillips, D. H. Mutational spectra and mutational signatures: insights into cancer aetiology and mechanisms of DNA damage and repair. DNA Repair. 71, 6\u201311 (2018).","journal-title":"DNA Repair."},{"key":"494_CR163","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1101\/gr.242453.118","volume":"29","author":"M Zhivagui","year":"2019","unstructured":"Zhivagui, M. et al. Experimental and pan-cancer genome analyses reveal widespread contribution of acrylamide exposure to carcinogenesis in humans. Genome Res. 29, 521\u2013531 (2019).","journal-title":"Genome Res."},{"key":"494_CR164","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/nm.3878","volume":"21","author":"D Nassar","year":"2015","unstructured":"Nassar, D., Latil, M., Boeckx, B., Lambrechts, D. & Blanpain, C. Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma. Nat. Med. 21, 946\u2013954 (2015).","journal-title":"Nat. Med."},{"key":"494_CR165","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nature13898","volume":"517","author":"PM Westcott","year":"2015","unstructured":"Westcott, P. M. et al. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer. Nature 517, 489\u2013492 (2015).","journal-title":"Nature"},{"key":"494_CR166","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/nm.3979","volume":"21","author":"MQ McCreery","year":"2015","unstructured":"McCreery, M. Q. et al. Evolution of metastasis revealed by mutational landscapes of chemically induced skin cancers. Nat. Med. 21, 1514\u20131520 (2015).","journal-title":"Nat. Med."},{"key":"494_CR167","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-021-03974-6","volume":"598","author":"SWK Ng","year":"2021","unstructured":"Ng, S. W. K. et al. Convergent somatic mutations in metabolism genes in chronic liver disease. Nature 598, 473\u2013478 (2021).","journal-title":"Nature"},{"key":"494_CR168","doi-asserted-by":"publisher","first-page":"7450461","DOI":"10.1155\/2016\/7450461","volume":"2016","author":"K Popovska-Jankovic","year":"2016","unstructured":"Popovska-Jankovic, K. et al. microRNA profiling in patients with upper tract urothelial carcinoma associated with Balkan endemic nephropathy. BioMed. Res. Int. 2016, 7450461 (2016).","journal-title":"BioMed. Res. Int."},{"key":"494_CR169","doi-asserted-by":"publisher","first-page":"6533","DOI":"10.3892\/mmr.2015.4330","volume":"12","author":"L Tao","year":"2015","unstructured":"Tao, L. et al. Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo. Mol. Med. Rep. 12, 6533\u20136546 (2015).","journal-title":"Mol. Med. Rep."},{"key":"494_CR170","first-page":"149750","volume":"2014","author":"S-M Wang","year":"2014","unstructured":"Wang, S.-M. et al. Increased upper and lower tract urothelial carcinoma in patients with end-stage renal disease: a nationwide cohort study in Taiwan during 1997\u20132008. BioMed. Res. Int. 2014, 149750\u2013149750 (2014).","journal-title":"BioMed. Res. Int."},{"key":"494_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-56394-y","volume":"9","author":"J-R Jhuang","year":"2019","unstructured":"Jhuang, J.-R., Chiang, C.-J., Su, S.-Y., Yang, Y.-W. & Lee, W.-C. Reduction in the incidence of urological cancers after the Ban on chinese Herbal products containing aristolochic acid: an interrupted time-series analysis. Sci. Rep. 9, 1\u20138 (2019). This study provides the first look into disease trends following the prohibition of AA-containing herbal products in Taiwan, showing a possible reduction in incidence rates of bladder cancer, carcinomas of the renal pelvis and other urinary organs consequent to the implementation of these prohibitions.","journal-title":"Sci. Rep."},{"key":"494_CR172","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1039\/C9RA08327H","volume":"10","author":"Y Fan","year":"2020","unstructured":"Fan, Y., Li, Z. & Xi, J. Recent developments in detoxication techniques for aristolochic acid-containing traditional Chinese medicines. RSC Adv. 10, 1410\u20131425 (2020).","journal-title":"RSC Adv."},{"key":"494_CR173","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/MOU.0000000000000765","volume":"30","author":"K Rebhan","year":"2020","unstructured":"Rebhan, K., Ertl, I. E., Shariat, S. F., Grollman, A. P. & Rosenquist, T. Aristolochic acid and its effect on different cancers in uro-oncology. Curr. Opin. Urol. 30, 689\u2013695 (2020).","journal-title":"Curr. Opin. Urol."},{"key":"494_CR174","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1007\/s00204-016-1819-3","volume":"90","author":"M Stiborov\u00e1","year":"2016","unstructured":"Stiborov\u00e1, M., Arlt, V. M. & Schmeiser, H. H. Balkan endemic nephropathy: an update on its aetiology. Arch. Toxicol. 90, 2595\u20132615 (2016).","journal-title":"Arch. Toxicol."},{"key":"494_CR175","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/toxics7010014","volume":"7","author":"C-K Chan","year":"2019","unstructured":"Chan, C.-K., Liu, Y., Pavlovi\u0107, N. M. & Chan, W. Aristolochic acids: newly identified exposure pathways of this class of environmental and food-borne contaminants and its potential link to chronic kidney diseases. Toxics 7, 14 (2019).","journal-title":"Toxics"},{"key":"494_CR176","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jep.2009.05.028","volume":"125","author":"M Heinrich","year":"2009","unstructured":"Heinrich, M., Chan, J., Wanke, S., Neinhuis, C. & Simmonds, M. S. Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2 \u2014 a global assessment based on bibliographic sources. J. Ethnopharmacol. 125, 108\u2013144 (2009).","journal-title":"J. Ethnopharmacol."},{"key":"494_CR177","doi-asserted-by":"publisher","first-page":"5928","DOI":"10.1021\/acs.jafc.6b02203","volume":"64","author":"W Chan","year":"2016","unstructured":"Chan, W. et al. Quantitation of aristolochic acids in corn, wheat grain, and soil samples collected in Serbia: identifying a novel exposure pathway in the etiology of Balkan endemic nephropathy. J. Agric. Food Chem. 64, 5928\u20135934 (2016).","journal-title":"J. Agric. Food Chem."},{"key":"494_CR178","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1021\/acs.est.9b05337","volume":"54","author":"K-K Tung","year":"2020","unstructured":"Tung, K.-K. et al. Occurrence and environmental stability of aristolochic acids in groundwater collected from Serbia: links to human exposure and Balkan endemic nephropathy. Environ. Sci. Technol. 54, 1554\u20131561 (2020).","journal-title":"Environ. Sci. Technol."},{"key":"494_CR179","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1021\/acs.jafc.5b05089","volume":"64","author":"W Li","year":"2016","unstructured":"Li, W., Hu, Q. & Chan, W. Uptake and accumulation of nephrotoxic and carcinogenic aristolochic acids in food crops grown in Aristolochia clematitis-contaminated soil and water. J. Agric. Food Chem. 64, 107\u2013112 (2016).","journal-title":"J. Agric. Food Chem."},{"key":"494_CR180","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10653-012-9477-8","volume":"35","author":"NM Pavlovi\u0107","year":"2013","unstructured":"Pavlovi\u0107, N. M. et al. Possible health impacts of naturally occurring uptake of aristolochic acids by maize and cucumber roots: links to the etiology of endemic (Balkan) nephropathy. Environ. Geochem. Health 35, 215\u2013226 (2013).","journal-title":"Environ. Geochem. Health"},{"key":"494_CR181","doi-asserted-by":"publisher","first-page":"134111","DOI":"10.1016\/j.chemosphere.2022.134111","volume":"297","author":"AT Lukinich-Gruia","year":"2022","unstructured":"Lukinich-Gruia, A. T. et al. Aristolochic acid I as an emerging biogenic contaminant involved in chronic kidney diseases: a comprehensive review on exposure pathways, environmental health issues and future challenges. Chemosphere 297, 134111 (2022).","journal-title":"Chemosphere"},{"key":"494_CR182","doi-asserted-by":"publisher","first-page":"137528","DOI":"10.1016\/j.scitotenv.2020.137528","volume":"720","author":"C-K Chan","year":"2020","unstructured":"Chan, C.-K., Tung, K.-K., Pavlovi\u0107, N. M. & Chan, W. Remediation of aristolochic acid-contaminated soil by an effective advanced oxidation process. Sci. Total. Environ. 720, 137528 (2020).","journal-title":"Sci. Total. Environ."},{"key":"494_CR183","doi-asserted-by":"publisher","first-page":"11468","DOI":"10.1021\/acs.jafc.8b04770","volume":"66","author":"W Li","year":"2018","unstructured":"Li, W. et al. Aristolochic acids as persistent soil pollutants: determination of risk for human exposure and nephropathy from plant uptake. J. Agric. Food Chem. 66, 11468\u201311476 (2018).","journal-title":"J. Agric. Food Chem."},{"key":"494_CR184","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.phymed.2006.05.009","volume":"14","author":"KM Wu","year":"2007","unstructured":"Wu, K. M., Farrelly, J. G., Upton, R. & Chen, J. Complexities of the herbal nomenclature system in traditional Chinese medicine (TCM): lessons learned from the misuse of Aristolochia-related species and the importance of the pharmaceutical name during botanical drug product development. Phytomedicine 14, 273\u2013279 (2007).","journal-title":"Phytomedicine"},{"key":"494_CR185","doi-asserted-by":"publisher","first-page":"619","DOI":"10.15252\/embr.201642375","volume":"17","author":"AP Grollman","year":"2016","unstructured":"Grollman, A. P. & Marcus, D. M. Global hazards of herbal remedies: lessons from Aristolochia. EMBO Rep. 17, 619\u2013625 (2016).","journal-title":"EMBO Rep."},{"key":"494_CR186","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41586-019-1670-9","volume":"574","author":"SF Brunner","year":"2019","unstructured":"Brunner, S. F. et al. Somatic mutations and clonal dynamics in healthy and cirrhotic human liver. Nature 574, 538\u2013542 (2019).","journal-title":"Nature"},{"key":"494_CR187","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.eururo.2011.03.027","volume":"59","author":"AR Zlotta","year":"2011","unstructured":"Zlotta, A. R. et al. Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non\u2013muscle-invasive bladder cancer. Eur. Urol. 59, 1026\u20131031 (2011).","journal-title":"Eur. Urol."},{"key":"494_CR188","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/ijc.28013","volume":"133","author":"C-H Chen","year":"2013","unstructured":"Chen, C.-H. et al. Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes. Int. J. Cancer 133, 14\u201320 (2013).","journal-title":"Int. J. Cancer"},{"key":"494_CR189","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s002040050568","volume":"72","author":"J-P Cosyns","year":"1998","unstructured":"Cosyns, J.-P. et al. Chinese herbs nephropathy-associated slimming regimen induces tumours in the forestomach but no interstitial nephropathy in rats. Arch. Toxicol. 72, 738\u2013743 (1998).","journal-title":"Arch. Toxicol."},{"key":"494_CR190","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1681\/ASN.V132431","volume":"13","author":"FD Debelle","year":"2002","unstructured":"Debelle, F. D. et al. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J. Am. Soc. Nephrol. 13, 431\u2013436 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"494_CR191","first-page":"1129","volume":"21","author":"Q Qiu","year":"2000","unstructured":"Qiu, Q., Liu, Z. H., Chen, H. P., Yin, H. L. & Li, L. S. Long-term outcome of acute renal injury induced by Aristolochia manshuriensis Kom in rats. Acta Pharmacol. Sin. 21, 1129\u20131135 (2000).","journal-title":"Acta Pharmacol. Sin."},{"key":"494_CR192","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/mutage\/gei007","volume":"20","author":"M Cui","year":"2005","unstructured":"Cui, M. Tumour induction in rats following exposure to short-term high dose aristolochic acid I. Mutagenesis 20, 45\u201349 (2005).","journal-title":"Mutagenesis"},{"key":"494_CR193","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/carcin\/14.3.407","volume":"14","author":"D Hadjiolov","year":"1993","unstructured":"Hadjiolov, D. et al. Effect of diallyl sulfide on aristolochic acid-induced forestomach carcinogenesis in rats. Carcinogenesis 14, 407\u2013410 (1993).","journal-title":"Carcinogenesis"},{"key":"494_CR194","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1046\/j.1523-1755.2001.00731.x","volume":"59","author":"J-P Cosyns","year":"2001","unstructured":"Cosyns, J.-P. et al. Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? Kidney Int. 59, 2164\u20132173 (2001).","journal-title":"Kidney Int."},{"key":"494_CR195","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1383-5718(01)00350-3","volume":"515","author":"A Kohara","year":"2002","unstructured":"Kohara, A., Suzuki, T., Honma, M., Ohwada, T. & Hayashi, M. Mutagenicity of aristolochic acid in the lambda\/lacZ transgenic mouse (Muta\u2122Mouse). Mutat. Res. Genet. Toxicol. Environ. Mutagen. 515, 63\u201372 (2002).","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"494_CR196","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4103\/wjtcm.wjtcm_33_19","volume":"6","author":"X-L Li","year":"2020","unstructured":"Li, X.-L., Guo, X.-Q., Wang, H.-R., Chen, T. & Mei, N. Aristolochic acid-induced genotoxicity and toxicogenomic changes in rodents. World J. Tradit. Chin. Med. 6, 12\u201325 (2020).","journal-title":"World J. Tradit. Chin. Med."},{"key":"494_CR197","first-page":"141","volume":"24","author":"Y-Y Chen","year":"2010","unstructured":"Chen, Y.-Y. et al. Aristolochic acid suppresses DNA repair and triggers oxidative DNA damage in human kidney proximal tubular cells. Oncol. Rep. 24, 141\u2013153 (2010).","journal-title":"Oncol. Rep."},{"key":"494_CR198","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.tiv.2011.01.016","volume":"25","author":"F-Y Yu","year":"2011","unstructured":"Yu, F.-Y., Wu, T.-S., Chen, T.-W. & Liu, B.-H. Aristolochic acid I induced oxidative DNA damage associated with glutathione depletion and ERK1\/2 activation in human cells. Toxicol. Vitr. 25, 810\u2013816 (2011).","journal-title":"Toxicol. Vitr."},{"key":"494_CR199","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.etap.2013.01.007","volume":"35","author":"D Nitzsche","year":"2013","unstructured":"Nitzsche, D., Melzig, M. F. & Arlt, V. M. Evaluation of the cytotoxicity and genotoxicity of aristolochic acid I\u2013A component of Aristolochiaceae plant extracts used in homeopathy. Environ. Toxicol. Pharmacol. 35, 325\u2013334 (2013).","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"494_CR200","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.tox.2019.03.013","volume":"420","author":"H Bastek","year":"2019","unstructured":"Bastek, H. et al. Comparison of aristolochic acid I derived DNA adduct levels in human renal toxicity models. Toxicology 420, 29\u201338 (2019).","journal-title":"Toxicology"},{"key":"494_CR201","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/0960327119897099","volume":"39","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Mitochondrial dysfunction is involved in aristolochic acid I-induced apoptosis in renal proximal tubular epithelial cells. Hum. Exp. Toxicol. 39, 673\u2013682 (2020).","journal-title":"Hum. Exp. Toxicol."},{"key":"494_CR202","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate, J. G. et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 47, D941\u2013D947 (2019).","journal-title":"Nucleic Acids Res."},{"key":"494_CR203","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/BF00295084","volume":"59","author":"U Mengs","year":"1987","unstructured":"Mengs, U. Acute toxicity of aristolochic acid in rodents. Arch. Toxicol. 59, 328\u2013331 (1987).","journal-title":"Arch. Toxicol."},{"key":"494_CR204","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF01973700","volume":"67","author":"U Mengs","year":"1993","unstructured":"Mengs, U. & Stotzem, C. D. Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology. Arch. Toxicol. 67, 307\u2013311 (1993).","journal-title":"Arch. Toxicol."},{"key":"494_CR205","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.taap.2012.07.008","volume":"266","author":"Z Jiang","year":"2013","unstructured":"Jiang, Z. et al. Possible role of mtDNA depletion and respiratory chain defects in aristolochic acid I-induced acute nephrotoxicity. Toxicol. Appl. Pharmacol. 266, 198\u2013203 (2013).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"494_CR206","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1124\/dmd.105.008706","volume":"34","author":"H Dong","year":"2006","unstructured":"Dong, H. et al. Quantitative determination of aristolochic acid-derived DNA adducts in rats using 32P-postlabeling\/polyacrylamide gel electrophoresis analysis. Drug Metab. Dispos. 34, 1122\u20131127 (2006).","journal-title":"Drug Metab. Dispos."},{"key":"494_CR207","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mrfmmm.2006.08.004","volume":"602","author":"N Mei","year":"2006","unstructured":"Mei, N., Arlt, V. M., Phillips, D. H., Heflich, R. H. & Chen, T. DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver. Mutat. Res. Fund. Mol. Mech. Mutagen. 602, 83\u201391 (2006).","journal-title":"Mutat. Res. Fund. Mol. Mech. Mutagen."},{"key":"494_CR208","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3904\/kjim.2018.280","volume":"35","author":"Y Quan","year":"2020","unstructured":"Quan, Y. et al. Assessment of nephrotoxicity of herbal medicine containing aristolochic acid in mice. Korean J. Intern. Med. 35, 400 (2020).","journal-title":"Korean J. Intern. Med."},{"key":"494_CR209","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ijc.25324","volume":"128","author":"VM Arlt","year":"2011","unstructured":"Arlt, V. M. et al. Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice. Int. J. Cancer 128, 21\u201332 (2011).","journal-title":"Int. J. Cancer"},{"key":"494_CR210","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-23565-2","volume":"8","author":"T Baudoux","year":"2018","unstructured":"Baudoux, T. et al. CD4+ and CD8+ T cells exert regulatory properties during experimental acute aristolochic acid nephropathy. Sci. Rep. 8, 1\u201312 (2018).","journal-title":"Sci. Rep."},{"key":"494_CR211","doi-asserted-by":"publisher","first-page":"F1006","DOI":"10.1152\/ajprenal.00675.2009","volume":"298","author":"L Zhou","year":"2010","unstructured":"Zhou, L. et al. Mechanism of chronic aristolochic acid nephropathy: role of Smad3. Am. J. Physiol. Ren. Physiol. 298, F1006\u2013F1017 (2010).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"494_CR212","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.toxlet.2019.04.027","volume":"312","author":"J Ye","year":"2019","unstructured":"Ye, J. et al. Aristolochic acid I aggravates renal injury by activating the C3a\/C3aR complement system. Toxicol. Lett. 312, 118\u2013124 (2019).","journal-title":"Toxicol. Lett."},{"key":"494_CR213","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.taap.2012.03.011","volume":"261","author":"Y-J Ding","year":"2012","unstructured":"Ding, Y.-J. & Chen, Y.-H. Developmental nephrotoxicity of aristolochic acid in a zebrafish model. Toxicol. Appl. Pharmacol. 261, 59\u201365 (2012).","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"(Suppl. 2)","key":"494_CR214","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-7-S2-S20","volume":"7","author":"T Chen","year":"2006","unstructured":"Chen, T. et al. Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats. BMC Bioinform. 7 (Suppl. 2), S20 (2006).","journal-title":"BMC Bioinform."},{"key":"494_CR215","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1681\/ASN.2007050537","volume":"18","author":"AP Grollman","year":"2007","unstructured":"Grollman, A. P. & Jelakovi\u0107, B. Role of environmental toxins in endemic (Balkan) nephropathy. J. Am. Soc. Nephrol. 18, 2817 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"494_CR216","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083408","volume":"8","author":"Y Zhou","year":"2013","unstructured":"Zhou, Y. et al. Aristolochic acid causes albuminuria by promoting mitochondrial DNA damage and dysfunction in podocyte. PloS ONE 8, e83408 (2013).","journal-title":"PloS ONE"},{"key":"494_CR217","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00204-014-1249-z","volume":"89","author":"V Romanov","year":"2015","unstructured":"Romanov, V., Whyard, T. C., Waltzer, W. C., Grollman, A. P. & Rosenquist, T. Aristolochic acid-induced apoptosis and G2 cell cycle arrest depends on ROS generation and MAP kinases activation. Arch. Toxicol. 89, 47\u201356 (2015).","journal-title":"Arch. Toxicol."},{"key":"494_CR218","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.semnephrol.2019.02.004","volume":"39","author":"R Correa-Rotter","year":"2019","unstructured":"Correa-Rotter, R. & Garc\u00eda-Trabanino, R. Mesoamerican nephropathy. Semin. Nephrol. 39, 263\u2013271 (2019).","journal-title":"Semin. Nephrol."},{"key":"494_CR219","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1053\/j.ajkd.2016.10.036","volume":"69","author":"J Wijkstrom","year":"2017","unstructured":"Wijkstrom, J. et al. Renal morphology, clinical findings, and progression rate in Mesoamerican nephropathy. Am. J. Kidney Dis. 69, 626\u2013636 (2017).","journal-title":"Am. J. Kidney Dis."},{"key":"494_CR220","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ekir.2016.11.003","volume":"2","author":"FJ Gifford","year":"2017","unstructured":"Gifford, F. J., Gifford, R. M., Eddleston, M. & Dhaun, N. Endemic nephropathy around the world. Kidney Int. Rep. 2, 282\u2013292 (2017).","journal-title":"Kidney Int. Rep."},{"key":"494_CR221","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.celrep.2012.12.008","volume":"3","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J. & Stratton, M. R. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 3, 246\u2013259 (2013).","journal-title":"Cell Rep."},{"key":"494_CR222","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41568-021-00377-7","volume":"21","author":"G Koh","year":"2021","unstructured":"Koh, G., Degasperi, A., Zou, X., Momen, S. & Nik-Zainal, S. Mutational signatures: emerging concepts, caveats and clinical applications. Nat. Rev. Cancer 21, 619\u2013637 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"494_CR223","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-021-04450-8","volume":"22","author":"S Senkin","year":"2021","unstructured":"Senkin, S. MSA: reproducible mutational signature attribution with confidence based on simulations. BMC Bioinforma. 22, 540 (2021).","journal-title":"BMC Bioinforma."},{"key":"494_CR224","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s43018-020-0027-5","volume":"1","author":"A Degasperi","year":"2020","unstructured":"Degasperi, A. et al. A practical framework and online tool for mutational signature analyses show inter-tissue variation and driver dependencies. Nat. Cancer 1, 249\u2013263 (2020).","journal-title":"Nat. Cancer"},{"key":"494_CR225","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-1951-5","volume":"21","author":"G Koh","year":"2020","unstructured":"Koh, G., Zou, X. & Nik-Zainal, S. Mutational signatures: experimental design and analytical framework. Genome Biol. 21, 37 (2020).","journal-title":"Genome Biol."},{"key":"494_CR226","doi-asserted-by":"publisher","first-page":"503195","DOI":"10.1016\/j.mrgentox.2020.503195","volume":"853","author":"PN Melki","year":"2020","unstructured":"Melki, P. N., Korenjak, M. & Zavadil, J. Experimental investigations of carcinogen-induced mutation spectra: innovation, challenges and future directions. Mutat. Res. Genet. Toxicol. Env. Mutagen. 853, 503195 (2020).","journal-title":"Mutat. Res. Genet. Toxicol. Env. Mutagen."},{"key":"494_CR227","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1021\/acs.chemrestox.9b00339","volume":"32","author":"J Zavadil","year":"2019","unstructured":"Zavadil, J. & Rozen, S. G. Experimental delineation of mutational signatures is an essential tool in cancer epidemiology and prevention. Chem. Res. Toxicol. 32, 2153\u20132155 (2019).","journal-title":"Chem. Res. Toxicol."},{"key":"494_CR228","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04052-8","volume":"9","author":"X Zou","year":"2018","unstructured":"Zou, X. et al. Validating the concept of mutational signatures with isogenic cell models. Nat. Commun. 9, 1744 (2018).","journal-title":"Nat. Commun."},{"key":"494_CR229","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04207-6","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu, Y., Chua, E. H. Z., Ng, A. W. T., Boot, A. & Rozen, S. G. Accuracy of mutational signature software on correlated signatures. Sci. Rep. 12, 390 (2022).","journal-title":"Sci. Rep."}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41568-022-00494-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-022-00494-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-022-00494-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T22:09:42Z","timestamp":1668550182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41568-022-00494-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":229,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["494"],"URL":"https:\/\/doi.org\/10.1038\/s41568-022-00494-x","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]},"assertion":[{"value":"15 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}